After an unsuccessful percutaneous coronary intervention for chronic total occlusion, subintimal tracking and reentry with ...

Percutaneous coronary intervention (PCI) with stenting is increasingly being utilized for acute coronary syndromes (ACS), and the debate over the safety and efficacy of drug-eluting stents (DESs) ...

Facilitated percutaneous coronary intervention (PCI) refers to using fibrinolytic therapy to stabilize the patient while transport is being arranged to a primary PCI facility. This strategy receives a ...

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

The use of an intracoronary hemodynamic technique, such as FRACTIONAL FLOW RESERVE (FFR), to determine the severity of a stenosis, can help when deciding whether to perform percutaneous coronary ...

WINNIPEG, Dec. 17, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the completion of the ...

KENGREAL, a synthetic, small molecule, is indicated as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial infarction (MI), repeat coronary ...

The global Percutaneous Coronary Intervention Market size is predicted to touch USD 15.20 billion at a 7.1% CAGR over the forecast period (2017-2023), in accordance with the latest Market Research ...

The "Global Percutaneous Coronary Intervention (PCI) Devices Market 2017-2021" report has been added to Research and Markets' offering. The global percutaneous coronary intervention (PCI) devices ...